⚕️ The information below is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Starting a GLP-1 medication like semaglutide (Ozempic) or tirzepatide (Mounjaro) is not a "start high and lose fast" treatment. Both medications use a structured dose escalation protocol — you begin at a very low dose and increase gradually, typically every 4 weeks. This titration process is the single most important factor in determining your side effect burden. Get it right, and you'll barely notice the transition. Rush it, and you may spend weeks battling nausea, vomiting, and fatigue severe enough to quit the medication entirely.
Consult your healthcare provider before starting any medication or adjusting your dose.
GLP-1 medications act simultaneously on the gut, liver, pancreas, and brain. The initial dose is deliberately tiny to allow your body to adapt to:
Jumping straight to the full therapeutic dose almost guarantees severe nausea and vomiting. Titration prevents this by allowing gradual receptor desensitisation.
Ozempic is injected once weekly subcutaneously — into the fatty tissue under the skin of the abdomen, thigh, or upper arm.
| Phase | Dose | Minimum Duration | What to Expect |
|---|---|---|---|
| Starting dose | 0.25 mg/week | 4 weeks | Mild nausea possible; mostly an adjustment phase |
| Step 1 | 0.5 mg/week | 4 weeks | Appetite reduction begins; some GI side effects |
| Step 2 | 1.0 mg/week | 4+ weeks | Significant appetite suppression; therapeutic dose for type 2 diabetes |
| Step 3 (if needed) | 2.0 mg/week | Ongoing | Maximum weight loss dose; only if 1mg is well-tolerated |
India pricing note: Ozempic is available in India as 0.25/0.5mg pens and 1mg pens. A 1mg pen (4 weekly doses) costs approximately ₹9,000–₹12,000 (May 2026). The 2mg dose requires separate prescribing and is less commonly available.
Mounjaro is also injected once weekly. Its titration is more gradual because it acts on both GLP-1 and GIP receptors simultaneously — a dual mechanism that is more potent but requires more careful adaptation.
| Phase | Dose | Minimum Duration | What to Expect |
|---|---|---|---|
| Starting dose | 2.5 mg/week | 4 weeks | Minimal side effects; body adapting |
| Step 1 | 5 mg/week | 4 weeks | Noticeable appetite suppression |
| Step 2 | 7.5 mg/week | 4 weeks | Continued weight loss; GI side effects may peak |
| Step 3 | 10 mg/week | 4 weeks | Strong appetite suppression |
| Step 4 | 12.5 mg/week | 4 weeks | Near-maximum effect |
| Maintenance | 15 mg/week | Ongoing | Maximum dose; SURMOUNT-1 trial showed up to 22.5% weight loss |
India pricing note: Mounjaro 2.5mg, 5mg, and 7.5mg KwikPens are available in India (May 2026) at approximately ₹8,000–₹15,000 per pen. Higher doses may require special procurement.
Many Indian endocrinologists and obesity specialists recommend staying at each dose for 6–8 weeks instead of the standard 4, especially for patients who:
This extended titration adds a few weeks to reaching the maintenance dose but dramatically reduces side effect burden and dropout rates.
Most patients feel little to nothing at starting doses. This is intentional — the therapeutic effect is minimal, but receptor adaptation begins.
Common effects: Mild nausea on injection day, slightly looser stools, mild reduction in appetite.
Practical tips:
This is where most patients notice both real benefits and real side effects for the first time.
Common effects: Nausea, constipation, burping, food aversions, fatigue in the first 48 hours after injection.
Practical tips:
GLP-1 therapeutic effects are now fully established. Weight loss accelerates. Most GI side effects improve by weeks 10–12 as your gut fully adapts.
Practical tips:
These doses provide maximum efficacy for weight loss.
Practical tips:
1. Rushing the dose increase — "I want to lose weight faster so I'll increase sooner." This backfires consistently. Severe nausea often leads to medication abandonment, wasting the investment.
2. Stopping the medication due to mild nausea — Mild nausea in the first 2–4 weeks is expected and resolves. Stopping unnecessarily means losing all progress and paying again when you restart.
3. Skipping injections — Inconsistent dosing resets your gut's adaptation process. Each missed week potentially restarts the side effect cycle. Inject on the same day each week.
4. Not reporting side effects to your doctor — Doctors can slow the titration schedule, prescribe anti-nausea medication, or adjust the injection timing. Suffering in silence is unnecessary.
5. Using borrowed or leftover pens — Dose consistency matters. Using someone else's pen introduces dose uncertainty and is medically unsound.
6. Self-escalating to higher doses — Higher doses require a valid prescription and medical monitoring. Do not self-prescribe above your current dose.
Stay at your current dose — do not increase — if you experience any of the following:
Stop the medication and go to emergency care immediately if you experience:
If you are using GLP-1 medications primarily for blood glucose control, your doctor may keep you at 0.5mg or 1mg semaglutide indefinitely once sugars are controlled. Maximum weight loss is not always the primary goal.
Slow titration is strongly advised. Consider extending each step to 6–8 weeks. Avoid lying down within 2 hours of eating — GLP-1's slowing of gastric emptying worsens reflux if meals are consumed too close to bedtime.
Metformin and GLP-1 medications are often combined and work synergistically. However, combined GI side effects can be significant early on. If nausea is severe, ask your doctor whether temporarily reducing metformin during GLP-1 initiation is appropriate.
Q: Can I split my weekly dose into smaller daily injections to reduce side effects?
No. Semaglutide and tirzepatide are specifically formulated for once-weekly subcutaneous dosing. Their extended half-lives (approximately 7 days for semaglutide) are designed around weekly injection. Splitting doses is not approved, may reduce efficacy, and adds injection site complications.
Q: My doctor prescribed 0.5mg but the pharmacy only has 1mg pens. What should I do?
Ozempic 1mg pens can be used to administer a 0.5mg dose — the device allows dialling specific amounts. Ask your pharmacist to demonstrate the correct dial setting. Never inject 1mg if your prescription says 0.5mg.
Q: I've been on 1mg semaglutide for 3 months and weight loss has stalled. Should I increase?
Discuss with your doctor. A dose increase to 2mg, combined with a dietary audit, often restarts weight loss after a plateau. However, a plateau after sustained loss may also indicate the need for a diet review rather than a dose change.
Q: Can I stay on a lower dose permanently if I feel well and am losing weight?
Yes. The goal is the minimum effective dose with maximum tolerability. Some patients achieve excellent outcomes at 0.5mg semaglutide or 5mg tirzepatide. There is no obligation to reach the maximum labelled dose.
Q: What happens if I miss an injection?
If you miss by 1–2 days, inject as soon as you remember, then resume your weekly schedule. If you missed by more than 5 days (for semaglutide), skip the missed dose and continue with your next scheduled injection. Do not double-dose.
Dose titration is not an obstacle — it is the therapy. Every week at a starting dose is your body learning to work with a powerful new hormonal signal. The patients who succeed long-term with GLP-1 medications are almost universally those who titrated patiently, communicated with their doctors, and did not abandon the medication during the first difficult weeks. Your investment in patience during months one and two pays dividends for years.
